User profiles for F. Abraha

Feven Abraha

Statistician, Mayo Clinic
Verified email at mayo.edu
Cited by 45

Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate …

…, JJ Orme, F Abraha, BJ Stish, VJ Lowe, F Lucien… - Clinical Cancer …, 2021 - AACR
Purpose: Outcomes for resistant metastatic castration-resistant prostate cancer (CRPC) are
poor. Stereotactic ablative radiotherapy (SABR) induces antitumor immunity in clinical and …

[HTML][HTML] Tumor-derived extracellular vesicles predict clinical outcomes in oligometastatic prostate cancer and suppress antitumor immunity

…, J Qian, JJ Orme, H Zhang, A Arafa, F Abraha… - International Journal of …, 2022 - Elsevier
Purpose SABR has demonstrated clinical benefit in oligometastatic prostate cancer. However,
the risk of developing new distant metastatic lesions remains high, and only a minority of …

[HTML][HTML] Crystal structure of an L chain optimised 14F7 anti-ganglioside Fv suggests a unique tumour-specificity through an unusual H-chain CDR3 architecture

…, JE Heggelund, HM Hoås, F Abraha… - Scientific reports, 2018 - nature.com
… (F) Thermostability of scFv C1 in the absence and presence of the NeuGc trisaccharide. (G) …
CDR L1-3 interact with V H residues Tyr100 E and Tyr100 F (Kabat numbering 64 ) and …

[HTML][HTML] Association of common medications and the risk of early-onset gastric cancer: a population-based matched study

…, WS Harmsen, J Mandrekar, F Abraha… - Journal of Cancer …, 2021 - hindawi.com
… Feven Abraha was responsible for formal analysis, data curation, investigation,
methodology, software, writing—review and editing. Travis E. Grotz was responsible for conceptualization…

Key role of a structural water molecule for the specificity of 14F7—An antitumor antibody targeting the NeuGc GM3 ganglioside

K Bjerregaard-Andersen, F Abraha… - …, 2021 - academic.oup.com
… density in the CDR regions and could be modeled without chain breaks, whereas parts of
CDR H3 could not be traced in the remaining two scFv molecules M3 and M4 (chains E + F

Synthesis of mucin O-glycan core structures as their p-nitro-and p-aminophenyl glycosides

M Hollinger, F Abraha, S Oscarson - Carbohydrate research, 2011 - Elsevier
… A sample of the pure β anomer was obtained by repeated FC on silica gel: R f 0.55 (toluene–EtOAc
5:2); [ α ] D 20 +100 (c 0.29, CHCl 3 ). H NMR (500 MHz, CDCL 3 ) δ 8.25–8.19 (m, …

[HTML][HTML] Single and multifraction spine stereotactic body radiation therapy and the risk of radiation induced myelopathy

JJ Lucido, TC Mullikin, F Abraha, WS Harmsen… - Advances in Radiation …, 2022 - Elsevier
Purpose This study reports on the risk of radiation-induced myelitis (RM) of the spinal cord
from a large single-institutional experience with 1 to 5 fraction stereotactic body radiation …

[HTML][HTML] Long-term outcomes of intraoperatively-placed applicator brachytherapy for rapid completion of breast conserving treatment: An analysis of a prospective …

H Kim, TJ Hieken, F Abraha, JW Jakub… - Clinical and …, 2023 - Elsevier
Background and purpose To evaluate the long-term outcome of accelerated partial breast
irradiation utilizing intraoperatively placed applicator-based brachytherapy (ABB) in early-…

Outcomes and patterns of recurrence for anaplastic thyroid cancer treated with comprehensive chemoradiotherapy

…, JC Morris, KM Van Abel, M Rivera, F Abraha… - Practical Radiation …, 2022 - Elsevier
Purpose Radiation therapy (RT) plays an important role in locoregional tumor control for
anaplastic thyroid cancer (ATC). Due to its rarity, RT guidelines for ATC are lacking. We …

Insight into glycosphingolipid crypticity: Crystal structure of the anti-tumor antibody 14F7 and recognition of NeuGc GM3 ganglioside

K Bjerregaard-Andersen, H Johannesen, F Abraha… - BioRxiv, 2020 - biorxiv.org
Tumor-associated glycolipids such as NeuGc GM3 are auspicious molecular targets in
antineoplastic therapies and vaccine strategies. 14F7 is an anti-tumor antibody with high clinical …